Henry Schein, Inc. (NASDAQ:HSIC) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share guidance of $7.17-7.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.29.

A number of research analysts have recently weighed in on the stock. Barrington Research raised their price objective on shares of Henry Schein from $196.00 to $198.00 and gave the stock an outperform rating in a research note on Wednesday, May 10th. Zacks Investment Research raised shares of Henry Schein from a hold rating to a buy rating and set a $204.00 price objective for the company in a research note on Thursday, May 25th. Credit Suisse Group reaffirmed a hold rating and issued a $160.00 target price on shares of Henry Schein in a research note on Thursday, July 13th. Craig Hallum assumed coverage on shares of Henry Schein in a research note on Tuesday, April 11th. They issued a hold rating for the company. Finally, Stifel Nicolaus lifted their target price on shares of Henry Schein from $174.00 to $178.00 and gave the stock a hold rating in a research note on Wednesday, May 10th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have given a buy rating to the company. The stock presently has an average rating of Hold and a consensus price target of $185.56.

Henry Schein, Inc. (HSIC) opened at 183.79 on Tuesday. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99. The firm has a market cap of $14.58 billion, a price-to-earnings ratio of 27.93 and a beta of 1.09. The company’s 50 day moving average is $183.44 and its 200 day moving average is $174.47.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.01. The firm had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.53% and a return on equity of 19.74%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.64 EPS. On average, equities analysts anticipate that Henry Schein, Inc. will post $7.29 earnings per share for the current year.

In other Henry Schein news, EVP Gerald A. Benjamin sold 12,578 shares of the business’s stock in a transaction that occurred on Thursday, May 11th. The shares were sold at an average price of $175.10, for a total value of $2,202,407.80. Following the completion of the sale, the executive vice president now directly owns 44,061 shares of the company’s stock, valued at $7,715,081.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.27% of the company’s stock.

WARNING: “Henry Schein, Inc. (NASDAQ:HSIC) Updates FY17 Earnings Guidance” was reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/08/08/henry-schein-inc-nasdaqhsic-updates-fy17-earnings-guidance.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.